Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,007 | 457 | 99.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $25.00 | 1 | 0.4% |
| Education | $8.35 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,702 | 102 | $0 (2024) |
| Lilly USA, LLC | $858.85 | 80 | $0 (2024) |
| ABBVIE INC. | $715.04 | 52 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $703.51 | 45 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $484.03 | 21 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $352.60 | 19 | $0 (2022) |
| PFIZER INC. | $343.06 | 25 | $0 (2024) |
| GlaxoSmithKline, LLC. | $328.64 | 19 | $0 (2023) |
| Phathom Pharmaceuticals, Inc. | $163.74 | 10 | $0 (2024) |
| Abbott Laboratories | $151.28 | 12 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,560 | 86 | Novo Nordisk Inc ($436.69) |
| 2023 | $1,111 | 66 | Novo Nordisk Inc ($340.73) |
| 2022 | $954.12 | 64 | Novo Nordisk Inc ($235.29) |
| 2021 | $1,026 | 67 | Novo Nordisk Inc ($244.41) |
| 2020 | $593.53 | 46 | Novo Nordisk Inc ($117.30) |
| 2019 | $916.96 | 70 | Lilly USA, LLC ($174.03) |
| 2018 | $339.63 | 23 | Novo Nordisk Inc ($73.85) |
| 2017 | $538.01 | 37 | GlaxoSmithKline, LLC. ($135.20) |
All Payment Transactions
459 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.30 | General |
| Category: DIABETES | ||||||
| 12/09/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/02/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $12.62 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Diabetes | ||||||
| 11/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: Diabetes | ||||||
| 11/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: Obesity | ||||||
| 10/25/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: DIABETES | ||||||
| 10/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: DIABETES | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Respiratory | ||||||
| 10/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.48 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: Diabetes | ||||||
| 09/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: Cardio-renal | ||||||
| 09/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.96 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $25.50 | General |
| Category: Obesity | ||||||
| 09/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $0.32 | General |
| Category: Obesity | ||||||
| 09/17/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: Diabetes | ||||||
| 09/12/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,676 | 2,952 | $387,445 | $165,677 |
| 2022 | 16 | 1,008 | 1,895 | $210,705 | $89,351 |
| 2021 | 26 | 1,281 | 2,807 | $248,362 | $125,658 |
| 2020 | 26 | 1,324 | 2,222 | $206,200 | $95,959 |
All Medicare Procedures & Services
89 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 267 | 669 | $127,110 | $64,654 | 50.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 209 | 357 | $61,047 | $25,835 | 42.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 177 | 299 | $35,880 | $17,117 | 47.7% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 111 | 383 | $44,746 | $12,424 | 27.8% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 110 | 378 | $48,746 | $11,890 | 24.4% |
| 96130 | Evaluation of psychological test, first hour | Office | 2023 | 68 | 68 | $13,600 | $6,156 | 45.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 75 | 75 | $5,625 | $5,395 | 95.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 36 | 36 | $6,300 | $4,294 | 68.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 13 | 13 | $4,550 | $3,663 | 80.5% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 68 | 68 | $6,800 | $2,787 | 41.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 79 | 80 | $4,000 | $2,275 | 56.9% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 43 | 65 | $6,175 | $1,892 | 30.6% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 40 | 40 | $4,957 | $1,874 | 37.8% |
| G0396 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | Office | 2023 | 68 | 68 | $7,480 | $1,754 | 23.4% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 91 | 91 | $3,835 | $1,532 | 40.0% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 86 | 86 | $3,440 | $1,147 | 33.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 13 | 13 | $455.00 | $369.72 | 81.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 16 | 49 | $1,225 | $310.80 | 25.4% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2023 | 68 | 68 | $544.00 | $127.30 | 23.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 11 | 12 | $420.00 | $104.90 | 25.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 27 | 34 | $510.00 | $74.80 | 14.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 208 | 327 | $55,917 | $24,504 | 43.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 210 | 337 | $40,440 | $17,930 | 44.3% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 47 | 328 | $38,429 | $11,911 | 31.0% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 46 | 331 | $37,610 | $11,249 | 29.9% |
About Dr. James Batey, MD
Dr. James Batey, MD is a Family Medicine healthcare provider based in Union City, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1235119033.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Batey, MD has received a total of $7,040 in payments from pharmaceutical and medical device companies, with $1,560 received in 2024. These payments were reported across 459 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($7,007).
As a Medicare-enrolled provider, Batey has provided services to 5,289 Medicare beneficiaries, totaling 9,876 services with total Medicare billing of $476,645. Data is available for 4 years (2020–2023), covering 89 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Union City, TN
- Active Since 01/18/2006
- Last Updated 07/30/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1235119033
Products in Payments
- JARDIANCE (Drug) $535.26
- Ozempic (Drug) $526.98
- Rybelsus (Drug) $411.27
- FARXIGA (Drug) $404.72
- TRULICITY (Drug) $387.29
- XARELTO (Drug) $352.60
- VRAYLAR (Drug) $349.24
- MOUNJARO (Drug) $231.37
- QULIPTA (Drug) $226.08
- Wegovy (Drug) $225.76
- RYBELSUS (Drug) $185.79
- TRADJENTA (Drug) $171.73
- Tresiba (Drug) $165.34
- VOQUEZNA (Drug) $163.74
- UBRELVY (Drug) $151.78
- Kerendia (Drug) $134.88
- ANORO (Drug) $133.65
- FreeStyle Libre Pro (Device) $114.99
- BASAGLAR (Drug) $107.98
- BREO (Drug) $98.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Union City
Dr. Jerry Jurado, M.d, M.D
Family Medicine — Payments: $63,292
Francisco Gonzalez, Md, MD
Family Medicine — Payments: $14,250
John Clendenin, M.d, M.D
Family Medicine — Payments: $11,619
John Hale, M.d, M.D
Family Medicine — Payments: $11,378
William Stone, M.d, M.D
Family Medicine — Payments: $11,291
Maria Paschalidis, D.o, D.O
Family Medicine — Payments: $10,936